Logo Image
News
Media
Clinical Forum InsightsPodcastsShortsState Of Sciences - PresentationsVideosWebinars
Multimedia Series
CURE Connections®InsightsMedcastPeer ExchangePeers & PerspectivesSpecial Report
Conferences
Conference CoverageConference Listing
More
Partners
CME/CE
Resources
Digital SupplementsInteractive ToolsLive EventsPress ReleasePublicationsSponsored
Advisory Board

Subscribe

  • News
  • Media
  • Multimedia Series
  • Conferences
  • Partners
  • CME/CE
  • Resources
  • Advisory Board
  • Subscribe
  • Allergy
    • Seasonal Allergy
    • Food Allergy
    • Anaphylaxis
  • Biosimilars
  • Cardiology
    • Dyslipidemia
    • Arrhythmia
    • Cardiomyopathy
    • Structural Heart Disease
    • Atherosclerotic Cardiovascular Disease
    • Heart Failure
    • Hypertension
    • Stroke
    • Venous Thromboembolism
  • Dermatology
    • Alopecia
    • Vitiligo
    • Hidradenitis Suppurativa
    • Acne
    • Atopic Dermatitis
    • Urticaria
    • Plaque Psoriasis
    • Rosacea
  • Endocrinology
    • Type 2 Diabetes
    • Type 1 Diabetes
    • Polycystic Ovary Syndrome
    • Hormonal Disorders
    • Thyroid Disorders
  • FDA News
  • Family Medicine
    • Influenza
    • Vaccination
  • Gastroenterology
    • Exocrine Pancreatic Insufficiency
    • Inflammatory Bowel Disease
    • C Difficile Infection
    • Gastroesophageal Reflux Disease (GERD)
    • Irritable Bowel Syndrome
    • Peptic Ulcer
    • Ulcerative Colitis
  • Geriatrics
    • Dementia and Alzheimer Disease
    • Parkinson Disease
  • Hematology
    • Paroxysmal Nocturnal Hemoglobinuria
    • Anemia
    • Sickle Cell
  • Hepatology
    • Alpha-1 antitrypsin deficiency
    • Cholangitis
    • MASH / MASLD
    • Hepatitis C
  • Hospital Medicine
  • Infectious Disease
    • COVID-19
    • HIV/AIDS
  • Internal Medicine
  • Nephrology
    • C3 Glomerulopathy
    • IgA Nephropathy
    • Focal Segmental Glomerulosclerosis
    • Chronic Kidney Disease
  • Neurology
    • Epilepsy
    • Migraine
    • Tardive Dyskinesia
    • Traumatic Brain Injury
  • Obesity Management
  • Ophthalmology
    • Geographic Atrophy
    • Age-Related Macular Degeneration
    • Diabetic Macular Edema
    • Uveitis
  • Pain
    • Acute Pain
    • Chronic Pain
    • Multiple Sclerosis
    • Neuropathic Pain
  • Pediatrics
  • Psychiatry
    • PTSD
    • Addiction
    • ADHD
    • Bipolar Disorder
    • Major Depressive Disorder
    • Schizophrenia
  • Pulmonology
    • Lung Cancer
    • Pulmonary Fibrosis
    • Asthma
    • COPD
  • RDR Alert®
    • Vasculitis
    • Amyloidosis
    • Huntington Disease
    • Lysosomal Storage Disorders
  • Rheumatology
  • Sleep
    • Obstructive Sleep Apnea
    • Insomnia
  • Surgery
    • Plastic surgery
  • Women's Health
Spotlight -
FDA News|
This Year In Medicine 2025
Advertisement

Thanai Pongdee, MD

Advertisement

Articles by Thanai Pongdee, MD

Looking Deeper Into ISM and KIT Mutations, with Thanai Pongdee, MD

Looking Deeper Into ISM and KIT Mutations, with Thanai Pongdee, MD

ByThanai Pongdee, MD
March 11th 2025

Pongdee also discussed the changing treatment landscape for indolent systemic mastocytosis and questions that will need to be answered in the field.

Improving Care for ISM With Better Diagnosis, Disease Characterization, with Thanai Pongdee, MD

Improving Care for ISM With Better Diagnosis, Disease Characterization, with Thanai Pongdee, MD

ByVictoria Johnson,Thanai Pongdee, MD
March 3rd 2025

Pongdee discussed research presented at the AAAAI/WAO Joint Congress that focused on improving diagnosis of indolent systemic mastocytosis.

Advertisement

Latest Updated Articles

  • Improving Care for ISM With Better Diagnosis, Disease Characterization, with Thanai Pongdee, MD
    Improving Care for ISM With Better Diagnosis, Disease Characterization, with Thanai Pongdee, MD

    March 3rd 2025



Advertisement
Advertisement

Trending on HCPLive

1

TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight

2

TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo

3

Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out

4

ACCESS: Aleniglipron Achieves Up To 11.3% Weight Loss in Phase 2b Obesity Trial

5

High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us